Home
Atara Biotherapeutics ATRA paid King & Spalding $30K for lobbying in Q3 2024 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $30,000
- Quarter
- Q3 2024
- Client
- Atara Biotherapeutics
- Reported
- 24/10/21
Up 0.0% from last quarter
What else happened in Atara Biotherapeutics around then
Filed or reported within 30 days of the trade day · 24/08/31~24/10/30Atara Biotherapeutics's other lobbying reports
- Atara Biotherapeutics
LobbyingAtara Biotherapeutics
LobbyingAtara Biotherapeutics
ATRA
$10K
$10K
Reported 07/20
for Q2
- Atara Biotherapeutics
LobbyingAtara Biotherapeutics
LobbyingAtara Biotherapeutics
ATRA
Under $5,000
Under $5,000
Reported 25/07/21
for Q2 2025
- Atara Biotherapeutics
LobbyingAtara Biotherapeutics
LobbyingAtara Biotherapeutics
ATRA
$30K
$30K
Reported 25/04/21
for Q1 2025
- Atara Biotherapeutics
LobbyingAtara Biotherapeutics
LobbyingAtara Biotherapeutics
ATRA
$30K
$30K
Reported 25/01/14
for Q4 2024
- Atara Biotherapeutics
LobbyingAtara Biotherapeutics
LobbyingAtara Biotherapeutics
ATRA
$30K
$30K
Reported 24/07/21
for Q2 2024